Pancreatic Cancer Research

Journal articleBiofactors2020

Skullcapflavone I has a potent anti-pancreatic cancer activity by targeting miR-23a.

Journal
Biofactors
Published
6 March 2020
Citations
6
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Baicalein has been widely studied and showed a potent activity against pancreatic cancer in both in vivo and in vitro studies. Little is known regarding the effects of Skullcapflavone I (SFI), despite they have similar structures. … Excerpt only: this text is the publisher’s. Read it in full at the source.